Results 81 to 90 of about 1,058 (155)

Influence of therapy chronic heart failure of functional class III on regulatory adaptive status

open access: yesКубанский научный медицинский вестник, 2014
100 patients with CHF FC III against the background of ischemic heart disease (IHD) and/or stage III hypertensive disease (HD). All them administered of complex therapy (Quinapril, Torasemide, Spironolactone).
E. S. Rokotyanskaya
doaj  

REGULATORY ADAPTIVE STATUS IN EVALUATION OF EFFECTIVENESS OF MEDICATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE OF FUNCTIONAL CLASS III

open access: yesКубанский научный медицинский вестник, 2014
100 patients with CHF FC III against the background of ischemic heart disease (IHD) and/or stage III hypertensive disease (HD) who received complex therapy (quinapril, torasemide, spironolactone) took part in the research.
E. S. Rokotyanskaya
doaj  

THE PRESCRIBING TRENDS OF ACE-INHIBITORS AFTER MYOCARDIAL INFARCTION IN TERTIARY CARE HOSPITALS OF HAZARA REGION

open access: yesInternational Journal of Pharmacy & Integrated Health Sciences
Background: There is good evidence that angiotensin-converting enzyme (ACE) inhibitors are beneficial after myocardial infarction (MI). However, it is not known how widely this evidence is used in practice or whether all eligible patients receive this ...
Fiaz Alam   +6 more
doaj   +1 more source

Overview of the clinical development of quinapril

open access: yesClinical Cardiology, 2009
Quinapril hydrochloride is the newest member of a family of angiotensin-converting enzyme (ACE) inhibitors. On completion of laboratory and animal studies, a clinical program was initiated to evaluate the antihypertensive and other properties of the drug in human subjects.
openaire   +2 more sources

Tendencia de la tensión arterial en mujeres con hipertensión arterial esencial-estadio II tratadas con un inhibidor de la enzima convertidora de angiotensina

open access: yesRevista de la Facultad de Medicina, 1995
Objetivo: Valorar el comportamiento de la tensión arterial en un grupo de mujeres con hipertensión arterial esencial- estadio II tratadas con guinapril, un inhibidor de la enzima convertidora de angiotensina. Métodos: se realizó un estudio epidemiológico
Mario E. Garcés Ferrer   +2 more
doaj  

Safety of Drugs in Breastfeeding Women With CKD

open access: yesKidney International Reports
Introduction: The benefits of breastfeeding are widely recognized. Because of lack of evidence, women may forego breastfeeding or decline treatments that impact long-term renal survival.
Paula Parnizari   +2 more
doaj   +1 more source

[The Study Group of Quinapril in Arterial Hypertension. The Steering Committee]

open access: yes, 1992
The efficacy and safety of the treatment of arterial hypertension with the ACE-inhibitor quinapril, were evaluated in a multicentre study conducted in Italy.
Brusca A   +9 more
core  

Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)

open access: yesBMC Pediatrics, 2009
Background The prognosis for young people diagnosed with diabetes during childhood remains poor and this is mainly related to the long-term risk of developing vascular complications.
doaj   +1 more source

A single (investigator)-blinded randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension

open access: yes, 2001
The effect of quinapril and nifedipine on platelet aggregation, vascular endothelial function and coagulation system activity, was compared in a parallel-group, investigator-blind study carried out on patients with mild to moderate hypertension but no ...
Islim, FI   +5 more
core   +1 more source

Adverse event of ACE inhibitors: A descriptive analysis of FAERS data

open access: yesJournal of Public Health Research
Background and objective: Angiotensin-converting enzyme inhibitors are first-line therapies for hypertension and related cardiovascular and renal conditions. The study aimed to characterize the adverse event profile of ACE inhibitors using the U.S.
Nehad Jaser Ahmed
doaj   +1 more source

Home - About - Disclaimer - Privacy